- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant Plasma Protein Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Plasma Protein Therapeuticsmarket, defines the market attractiveness level of Recombinant Plasma Protein Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Plasma Protein Therapeutics industry, describes the types of Recombinant Plasma Protein Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Plasma Protein Therapeutics market and the development prospects and opportunities of Recombinant Plasma Protein Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Plasma Protein Therapeutics market in Chapter 13.
By Player:
Pharming Group
Shire
CSL Limited
Novo Nordisk A/S
Takeda
Bioverativ Therapeutics
Pfizer
Octapharma
By Type:
Recombinant Coagulation Factors
Human C1 Esterase Inhibitor
By End-User:
Hemophilia A
Hemophilia B
Von Willebrand Disease
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Plasma Protein Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Plasma Protein Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Plasma Protein Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Plasma Protein Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Plasma Protein Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Plasma Protein Therapeutics Consumption (2017-2022)
-
7.2 United States Recombinant Plasma Protein Therapeutics Consumption (2017-2022)
-
7.3 Europe Recombinant Plasma Protein Therapeutics Consumption (2017-2022)
-
7.4 China Recombinant Plasma Protein Therapeutics Consumption (2017-2022)
-
7.5 Japan Recombinant Plasma Protein Therapeutics Consumption (2017-2022)
-
7.6 India Recombinant Plasma Protein Therapeutics Consumption (2017-2022)
-
7.7 South Korea Recombinant Plasma Protein Therapeutics Consumption (2017-2022)
8 Region and Country-wise Recombinant Plasma Protein Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Plasma Protein Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Plasma Protein Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Plasma Protein Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Recombinant Plasma Protein Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Plasma Protein Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Recombinant Plasma Protein Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Plasma Protein Therapeutics Consumption Forecast (2022-2028)
9 Global Recombinant Plasma Protein Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Plasma Protein Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Recombinant Coagulation Factors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Human C1 Esterase Inhibitor Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Plasma Protein Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hemophilia A Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hemophilia B Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Von Willebrand Disease Consumption and Growth Rate (2017-2022)
10 Global Recombinant Plasma Protein Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Plasma Protein Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Recombinant Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Human C1 Esterase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Plasma Protein Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hemophilia A Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Von Willebrand Disease Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Plasma Protein Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Plasma Protein Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Plasma Protein Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Plasma Protein Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Plasma Protein Therapeutics Market Competitive Analysis
-
14.1 Pharming Group
-
14.1.1 Pharming Group Company Details
-
14.1.2 Pharming Group Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pharming Group Recombinant Plasma Protein Therapeutics Product and Service
-
14.2 Shire
-
14.2.1 Shire Company Details
-
14.2.2 Shire Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shire Recombinant Plasma Protein Therapeutics Product and Service
-
14.3 CSL Limited
-
14.3.1 CSL Limited Company Details
-
14.3.2 CSL Limited Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CSL Limited Recombinant Plasma Protein Therapeutics Product and Service
-
14.4 Novo Nordisk A/S
-
14.4.1 Novo Nordisk A/S Company Details
-
14.4.2 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Product and Service
-
14.5 Takeda
-
14.5.1 Takeda Company Details
-
14.5.2 Takeda Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Recombinant Plasma Protein Therapeutics Product and Service
-
14.6 Bioverativ Therapeutics
-
14.6.1 Bioverativ Therapeutics Company Details
-
14.6.2 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Recombinant Plasma Protein Therapeutics Product and Service
-
14.8 Octapharma
-
14.8.1 Octapharma Company Details
-
14.8.2 Octapharma Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Octapharma Recombinant Plasma Protein Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Plasma Protein Therapeutics
-
Figure Recombinant Plasma Protein Therapeutics Picture
-
Table Global Recombinant Plasma Protein Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Plasma Protein Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Plasma Protein Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Plasma Protein Therapeutics Consumption by Country (2017-2022)
-
Figure United States Recombinant Plasma Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Plasma Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Plasma Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Plasma Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Plasma Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Plasma Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Plasma Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Plasma Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Plasma Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Plasma Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Plasma Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Plasma Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Plasma Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Coagulation Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Human C1 Esterase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia A Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia B Consumption and Growth Rate (2017-2022)
-
Figure Global Von Willebrand Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human C1 Esterase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Von Willebrand Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Plasma Protein Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Plasma Protein Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Pharming Group (Foundation Year, Company Profile and etc.)
-
Table Pharming Group Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharming Group Recombinant Plasma Protein Therapeutics Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Recombinant Plasma Protein Therapeutics Product and Service
-
Table CSL Limited (Foundation Year, Company Profile and etc.)
-
Table CSL Limited Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Recombinant Plasma Protein Therapeutics Product and Service
-
Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Recombinant Plasma Protein Therapeutics Product and Service
-
Table Bioverativ Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Recombinant Plasma Protein Therapeutics Product and Service
-
Table Octapharma (Foundation Year, Company Profile and etc.)
-
Table Octapharma Recombinant Plasma Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Recombinant Plasma Protein Therapeutics Product and Service
-